| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 468 | 9.009 | 6.693 | 2.829 | 746 | 0 | 0 | 24.998 | 109.773 |
| Total Income - EUR | 0 | 466 | 9.009 | 6.704 | 2.829 | 746 | 0 | 0 | 24.998 | 109.773 |
| Total Expenses - EUR | 0 | 12.999 | 3.308 | 8.531 | 3.292 | 3.001 | 2.513 | 5.078 | 33.147 | 99.447 |
| Gross Profit/Loss - EUR | 0 | -12.533 | 5.701 | -1.827 | -463 | -2.254 | -2.513 | -5.078 | -8.149 | 10.326 |
| Net Profit/Loss - EUR | 0 | -12.547 | 5.427 | -2.028 | -548 | -2.275 | -2.513 | -5.078 | -8.365 | 8.044 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - West Side Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.658 | 8.526 | 5.640 | 4.640 | 3.671 | 2.738 | 1.834 | 0 | 0 | 0 |
| Current Assets | 14.148 | 6.489 | 13.902 | 2.012 | 2.663 | 3.205 | 2.940 | 54 | 10.073 | 32.310 |
| Inventories | 14.028 | 6.385 | 6.541 | 1.896 | 2.614 | 2.721 | 2.660 | 0 | 7.272 | 26.627 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 736 | 1.991 |
| Cash | 120 | 104 | 7.360 | 116 | 49 | 484 | 280 | 54 | 2.065 | 3.693 |
| Shareholders Funds | 45 | -12.502 | -6.025 | -7.932 | -8.327 | -9.906 | -12.200 | -17.163 | -25.476 | -17.290 |
| Social Capital | 45 | 45 | 44 | 54 | 53 | 52 | 51 | 203 | 202 | 201 |
| Debts | 29.420 | 27.517 | 25.567 | 14.583 | 14.661 | 15.849 | 16.974 | 17.216 | 35.549 | 49.600 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - West Side Pharma S.r.l.